Adam Hosszu, PhD
I am a molecular biologist at the translational research laboratory of the 1st Department of Pediatrics, Semmelweis University with a special interest in nephrology and transplantation. I work as a postdoctoral researcher in a research group of the Hungarian Academy of Sciences led by Andrea Fekete, MD, DSc. My research focuses on the molecular mechanisms of various renal diseases with focus on hypoxic injury associated with transplantation.
Our group recently identified a promising novel drug to minimize graft injury and to improve transplantation outcomes. Preclinical studies have been completed and the European patent in which I am an inventor has been filed.
I spent a year at Prof. Christopher Wilcox's laboratory at Georgetown University, where I obtained experience in international collaboration and took part in drug development aimed at reducing hypertension-induced kidney damage.
In 2018 I spent 4 months at Prof. Thoralf Niendorf's experimental ultra-high field MRI laboratory at the Max Delbrück Center for Molecular Medicine, Berlin, Germany within the framework of the EU-COST action PARENCHIMA, with the goal of learning functional MR imaging techniques of the kidney and subsequently implementing this cutting-edge technique into translational research and human diagnostics.
Having worked at several labs abroad and working in an international team presently, I gained indispensable experience in collaboration with researchers from around the globe.